Okay, let's tackle this question. The user wants to know which tumor marker is elevated in both hepatocellular carcinoma (HCC) and testicular cancer. First, I need to recall the common tumor markers for each of these cancers.

HCC is typically associated with alpha-fetoprotein (AFP). Elevated AFP is a classic marker for HCC. But testicular cancers can be either seminomas or non-seminomas. Non-seminomas often produce markers like AFP, human chorionic gonadotropin (hCG), or lactate dehydrogenase (LDH). So, if a testicular cancer is non-seminomatous, AFP could be elevated. Therefore, AFP might be the answer here.

Wait, are there other markers that both cancers share? Let me think. For example, hCG is more specific for certain testicular tumors like choriocarcinoma or some germ cell tumors. But HCC doesn't typically raise hCG. So that's probably not the right answer. LDH is a nonspecific marker, elevated in many cancers, but not specific to either. Carcinoembryonic antigen (CEA) is more for colorectal cancer. CA 19-9 is for pancreatic, etc. So the only overlap seems to be AFP.

So the correct answer should be AFP. Let me verify. Yes, HCC and non-seminomatous testicular cancers both can have elevated AFP. So the answer is AFP.

**Core Concept**
This question tests knowledge of tumor markers for hepatocellular carcinoma (HCC) and testicular cancer. **Alpha-fetoprotein (AFP)** is a key oncofetal antigen elevated in both malignancies, reflecting shared embryonic origins of these tumors.

**Why the Correct Answer is Right**
**Alpha-fetoprotein (AFP)** is synthesized by fetal hepatocytes and yolk sac cells. In HCC, dysplastic hepatocytes resume AFP production. In testicular cancer, **non-seminomatous germ cell tumors** (e.g., embryonal carcinoma, yolk sac tumor) express AFP due to recapitulation of fetal yolk sac differentiation. Serum AFP levels correlate with tumor burden and are used for diagnosis, staging, and monitoring response to therapy in both cancers.

**Why Each Wrong Option is Incorrect**
**Option A:** **Beta-human chorionic gonadotropin (β-hCG)** is elevated in choriocarcinoma and some testicular germ cell tumors but not in HCC.
**Option B:** **Carcinoembryonic antigen (CEA)** is elevated in colorectal and other gastrointestinal cancers, not HCC or testicular tumors.
**Option C:** **Lactate dehydrogenase (LDH)** is a nonspecific marker of tissue damage and may be elevated in many cancers, but it is not specific to HCC or testicular cancer.

**Clinical Pearl / High-Yield Fact**
**Remember the "Tumor Marker Triad":** For germ cell tumors, **AFP (α-fetoprotein)**, **β-hCG**, and **LDH** are the primary markers. AFP is specific for **non-seminomatous** testicular tumors and **HCC**, while β-hCG is specific for **choriocarcinoma** and **some seminomas

✓ Correct Answer: A. AFP